Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02531607 · ClinicalTrials.gov registry record
Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)
A clinical trial of Pancreatic Neoplasms, sponsored by AdventHealth.
- Active
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT02531607 is a study of Pancreatic Neoplasms that is active but no longer recruiting, run by AdventHealth. The registered enrollment target is 500 participants, below the 585-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02531607, a study of Pancreatic Neoplasms, is active but no longer recruiting, sponsored by AdventHealth.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a non-randomized natural history protocol in which patients undergoing surgery or endoscopy for suspected/ diagnosed pancreaticobiliary strictures are assigned to a) control (chronic pancreatitis, no pancreatic neoplasm, primary sclerosing cholangitis), b) non-carcinoma (bile duct stones, papillary stenosis, ), c) carcinoma non-pancreatic (ampullary and distal bile duct or cholangiocarcinoma) and d) pancreatic ductal adenocarcinoma (pancreatic cancer.
Conditions Studied
Interventions
- OTHER blood and bile
Study Locations (1)
Florida
- AdventHealth - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2014-11-13 |
| Est. Completion | 2026-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02531607
The ClinicalTrials.gov registry entry for NCT02531607 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (15% lower). The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which blood and bile is the first listed.
NCT02531607 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02531607 about?
NCT02531607 is a clinical study titled "Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)". This is a non-randomized natural history protocol in which patients undergoing surgery or endoscopy for suspected/ diagnosed pancreaticobiliary strictures are assigned to a) control (chronic pancreatitis, no pancreatic neoplasm, primary sclerosing cholangitis), b) non-carcinoma (bile duct stones, pa...
What is the current status of trial NCT02531607?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2014-11-13. Estimated completion is 2026-12-01.
What conditions does trial NCT02531607 study?
This clinical trial studies the following conditions: Pancreatic Neoplasms.
What interventions are being tested in trial NCT02531607?
The interventions under investigation include: blood and bile (OTHER).
Who is sponsoring clinical trial NCT02531607?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02531607 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
RECRUITING
-
Determining Individualized Cancer Therapy in Pancreatic Cancer
RECRUITING
-
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
RECRUITING · Phase 2
-
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RECRUITING
-
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
RECRUITING
-
UCSF PANC Cyst Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.